European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024
May 31 - Jun 3, 2024
- Title: Efficacy and Safety of Oral Deucrictibant, a Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial
Presenter: Emel Aygören-Pürsün, M.D.
Format: Oral Presentation
Date, time: Saturday, June 1, 17:21 CEST (11:21 a.m. EDT) - Title: Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema
Presenter: Anna Valerieva, M.D., Ph.D.
Format: Oral Presentation
Date, time: Saturday, June 1, 17:33 CEST (11:33 a.m. EDT) - Title: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design
Presenter: Marcus Maurer, M.D.
Format: Poster (Flash Talk) Presentation
Date, time: Sunday, June 2, 13:15 CEST (7:15 a.m. EDT) - Title: Exploring the Relationship Between Airway Attacks and Patient-Reported Outcomes in Hereditary Angioedema Attacks
Presenter: Laurence Bouillet, M.D., Ph.D.
Format: Poster (Flash Talk) Presentation
Date, time: Sunday, June 2, 13:15 CEST (7:15 a.m. EDT) - Title: Pharmacodynamic Effects of Deucrictibant on Carrageenan-induced Edema in Humanized Bradykinin B2 Receptor Transgenic Sprague Dawley Rat
Presenter: Anne Lesage, Ph.D.
Format: Poster (Flash Talk) Presentation
Date, time: Sunday, June 2, 13:15 CEST (7:15 a.m. EDT) - Title: Development of Kallikrein-Kinin System Biomarker Assays to Investigate Bradykinin-mediated Diseases
Presenter: Evangelia Pardali, Ph.D.
Format: Poster (Flash Talk) Presentation
Date, time: Sunday, June 2, 13:15 CEST (7:15 a.m. EDT)